Lv11
38 积分 2025-02-20 加入
A comparison of methods for the estimation of retroviral burden
2小时前
求助中
Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas
2天前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
1个月前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
1个月前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
1个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
1个月前
已完结
Clinical Pharmacology Considerations on Recombinant Adeno‐Associated Virus–Based Gene Therapy
1个月前
已完结
Rational Clinical Dose Selection of Adeno‐Associated Virus‐Mediated Gene Therapy Based on Allometric Principles
1个月前
已完结
PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position Paper
1个月前
已完结
The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets
2个月前
已完结
皖公网安备34019202002308
